¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"B21"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
1
ÄÚµå
¿µ¹®
ÇѱÛ
B21.1
HIV disease resulting in Burkitt's lymphoma
¹öŰƮ ¸²ÇÁÁ¾À» À¯¹ßÇÑ HIVº´
B21.0
HIV disease resulting in Kaposi's sarcoma
Ä«Æ÷½Ã À°Á¾À» À¯¹ßÇÑ HIVº´
B21.7
HIV disease resulting in multiple malignant neoplasms
´Ù¹ß¼º ¾Ç¼º½Å»ý¹°À» À¯¹ßÇÑ HIVº´
B21.8
HIV disease resulting in other malignant neoplasms
±âŸ ¾Ç¼º½Å»ý¹°À» À¯¹ßÇÑ HIVº´
B21.3
HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
¸²ÇÁ¸ð¾ç, Á¶Ç÷¼º ¹× °ü·Ã Á¶Á÷ÀÇ ±âŸ ¾Ç¼º½Å»ý¹°À» À¯¹ßÇÑ HIVº´
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
ÄÚµå
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½